AKT1 and type 2 diabetes mellitus: Moreover, ALA treatment increased PI3K/Akt protein expression levels, suppressed expression of lipid synthesis transcription factor SREBP‐1c, and increased the protein expression of lipid oxidative enzyme CPT‐1, subsequently alleviating TG accumulation in the livers of T2DM rats (Figure 6).